These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14997326)

  • 1. Splenectomy in cytoreductive surgery for advanced ovarian cancer.
    Bilgin T; Ozerkan K; Ozan H
    Arch Gynecol Obstet; 2005 Apr; 271(4):329-31. PubMed ID: 14997326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenectomy as part of cytoreductive surgery in ovarian cancer.
    Magtibay PM; Adams PB; Silverman MB; Cha SS; Podratz KC
    Gynecol Oncol; 2006 Aug; 102(2):369-74. PubMed ID: 16631919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenectomy and surgical cytoreduction for ovarian cancer.
    Chen LM; Leuchter RS; Lagasse LD; Karlan BY
    Gynecol Oncol; 2000 Jun; 77(3):362-8. PubMed ID: 10831343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.
    Park JY; Seo SS; Kang S; Lee KB; Lim SY; Choi HS; Park SY
    Gynecol Oncol; 2006 Dec; 103(3):977-84. PubMed ID: 16837030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
    Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
    Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer.
    Chi DS; Abu-Rustum NR; Sonoda Y; Im HB; Jhamb N; D'Angelica M; Rim M; Dupont J; Barakat RR
    Gynecol Oncol; 2006 May; 101(2):224-7. PubMed ID: 16337997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
    Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
    Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer.
    McCann CK; Growdon WB; Munro EG; Del Carmen MG; Boruta DM; Schorge JO; Goodman A
    Ann Surg Oncol; 2011 Oct; 18(10):2912-8. PubMed ID: 21424880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
    Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
    Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer.
    Alphs HH; Zahurak ML; Bristow RE; Díaz-Montes TP
    Gynecol Oncol; 2006 Dec; 103(3):1048-53. PubMed ID: 16876237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.
    Manci N; Bellati F; Muzii L; Calcagno M; Alon SA; Pernice M; Angioli R; Panici PB
    Ann Surg Oncol; 2006 Dec; 13(12):1717-23. PubMed ID: 16957965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy as part of cytoreductive surgery for ovarian carcinoma.
    Nicklin JL; Copeland LJ; O'Toole RV; Lewandowski GS; Vaccarello L; Havenar LP
    Gynecol Oncol; 1995 Aug; 58(2):244-7. PubMed ID: 7622112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery in advanced borderline tumors.
    Viganò R; Petrone M; Pella F; Rabaiotti E; De Marzi P; Mangili G
    Fertil Steril; 2010 Aug; 94(3):1163-5. PubMed ID: 20036359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
    Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
    J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diaphragm resection for ovarian cancer: technique and short-term complications.
    Cliby W; Dowdy S; Feitoza SS; Gostout BS; Podratz KC
    Gynecol Oncol; 2004 Sep; 94(3):655-60. PubMed ID: 15350355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.